Remove Doctor Remove Pharmacy Remove Regulation
article thumbnail

Our abysmal health care system

World of DTC Marketing

First, the health insurance companies are making a lot of money while burying doctors in paperwork and limiting treatment options. Patients and doctors are tired, and insurance companies are raising rates after two years of making a surplus because nobody went to the doctor during the pandemic. The result:?

Doctors 263
article thumbnail

Disruption in healthcare is coming

World of DTC Marketing

The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . The new initiative, Care Studio, aims at doctors rather than patients. If pharmacies try to fill those generic prescriptions, the claims are rejected. Google is also giving health records another whirl.

Pharmacy 227
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

U.S. Pharmacy Chains Harm Patients With Medication Errors; NABP Appears Silent

Pharmacy Checkers

When you go to your local CVS and Walgreens – and other big pharmacy chains – are you getting the highest standard of care? Have these pharmacies gone rogue? Yet the National Association of Boards of Pharmacy (NABP) doesn’t seem to be paying much attention to medication errors at U.S. pharmacies. pharmacy industry.

article thumbnail

The social media problem for healthcare

World of DTC Marketing

From my estimates, most of it failed because pharma companies are afraid of misinformation concerning regulations around DTC marketing. I believe too many are making treatment decisions because they don’t have a close relationship with their doctors; even if one person makes a wrong decision, that is one person too many.

Branding 224
article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

FDA Law Blog

Houck — Separate decisions by federal district courts in Texas and Puerto Rico in the past two months provide cautionary tales for every pharmacy and wholesale distributor dispensing or distributing controlled substances. This post examines the Zarzamora pharmacy and prescribing red flags decision. d/b/a CVS/Pharmacy, Nos.

Pharmacy 139
article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.

article thumbnail

Good Doc, Bad Doc: Supreme Court Finds Prescriber Knowledge Counts

FDA Law Blog

This consolidated case has implications not only for prescribers of controlled substances but also for pharmacists and pharmacies who are subject to a “corresponding responsibility” to only fill prescriptions issued for a legitimate medical purpose pursuant to the Controlled Substances Act (21 U.S.C. §